Impact of population pharmacokinetic (PK) modeling, logistic regression and PK/pharmacodynamic (PD) simulation of solabeoron to aid in the dose selection of a phase IIB study in patients with irritable dowel syndrome (IBS).

被引：0
|
作者：
Cox, Donna S.
Boyle, Duane A.
Foss, Michael J.
机构：
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
14
引用
收藏
页码：1101 / 1101
页数：1
相关论文
共 26 条
  • [1] Population pharmacokinetic (PK) and pharmacodynamic (PD) modeling of etanercept using logistic regression analysis.
    Lee, H
    Kimko, HC
    Rogge, M
    Wang, D
    Nestorov, I
    Peck, CC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P84 - P84
  • [2] Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling and Trial Simulation for Selection of Optimal Dose of Fedratinib (SAR302503)
    Liu, Li
    Xu, Christine
    Su, Yaming
    Ma, Lei
    Quan, Hui
    Kanamaluru, Vanaja
    Shun, Zhenming
    Deutsch, Paul
    Zaks, Tal
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S18 - S18
  • [3] Dose selection by PK-PD modeling and simulation for a one year phase 2 proof of concept (POC) study
    Gao, X.
    Sweeney, K.
    Checchio, T.
    Plowchalk, D.
    Fryburg, D.
    Benincosa, L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1063 - 1063
  • [4] Pharmacokinetic/pharmacodynamic (PK/PD) modeling and dose regimen simulations to guide dose selection in phase 2a of an antisense oligonucleotide, targeting human apoB, in hypercholesterolemic subjects
    Yu, Rosie Z.
    Geary, Richard S.
    Bradley, JoAnn
    Chuang, Emil
    Wedel, Mark
    Fuhr, Rainard
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1068 - 1068
  • [5] Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia
    Ghanima, Waleed
    McDonald, Vickie
    Jain, Shivi
    Carpenedo, Monica
    Oliva, Esther N.
    Hultberg, Anna
    Gandini, Domenica
    Hofman, Erik
    Van Bragt, Tonke
    Parys, Wim
    van Hoorick, Benjamin
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    [J]. BLOOD, 2021, 138
  • [6] EXPOSURE-RESPONSE RELATIONSHIPS OF AMG 386 IN COMBINATION WITH WEEKLY PACLITAXEL IN ADVANCED OVARIAN CANCER: FACILITATION OF PHASE 3 DOSE SELECTION BY POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING
    Lu, J.
    Rasmussen, E.
    Navale, L.
    Kuchimanchi, M.
    Hurh, E.
    Karlan, B. Y.
    Vergote, I. B.
    Stepan, D. E.
    Weinreich, D. M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 308 - 308
  • [7] Exposure-response relationships of AMG 386 in combination with weekly paclitaxel in advanced ovarian cancer: Population pharmacokinetic/pharmacodynamic (PK/PD) modeling to facilitate phase III dose selection
    Lu, J.
    Rasmussen, E.
    Navale, L.
    Kuchimanchi, M.
    Hurh, E.
    Karlan, B. Y.
    Vergote, I. B.
    Stepan, D. E.
    Weinreich, D. M.
    Sun, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study
    Xu, Hongmei
    Li, Jianguo
    Webber, Lorraine
    Kakkar, Rahul
    Chen, Yingxue
    Al-Huniti, Nidal
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 999 - 1008
  • [9] MECHANISTIC PK/PD MODELING AND SIMULATION OF BEPIROVIRSEN PK, HBsAg AND ALT CHANGES FROM PHASE 2b STUDY TO INFORM PHASE 3 STUDY DESIGN AND DOSE SELECTION: B-CLEAR STUDY
    Youssef, Amir
    Ismail, Mohamed
    Mager, Donald E.
    Santulli, Andrew
    Magee, Mindy
    Theodore, Dickens
    Paff, Melanie
    Nader, Ahmed
    [J]. HEPATOLOGY, 2023, 77 (05) : E164 - E165
  • [10] PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) SIMULATIONS GUIDE SELECTION OF THE DOSE FOR ADMINISTRATION OF EFGARTIGIMOD PH20 SUBCUTANEOUSLY IN A PHASE 3 CLINICAL TRIAL IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
    Ghanima, W.
    McDonald, V.
    Jain, S.
    Carpenedo, M.
    Oliva, E. N.
    Hultberg, A.
    Gandini, D.
    Hofman, E.
    Van Bragt, T.
    Parys, W.
    van Hoorick, B.
    Godar, M.
    Rocca, F.
    Miyakawa, Y.
    Broome, C. M.
    [J]. HAEMATOLOGICA, 2022, 107 : 94 - 94
123